Biotricity, Inc. (BTCY)
OQB · Healthcare · Medical Devices
Closing price as of 2026-06-12 · Source: TEK2day Finance
Key Metrics
About Biotricity, Inc.
Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux and Biocore Pro, an integrated ECG device and software that utilizes wet electrodes for cardiac outpatient monitoring (COM) market; Biocore, a Holter and Extended Holter monitors for cardiac diagnostics; Biocare which support medical practitioners to gather data, and regularly monitor and treat patients with two or more chronic care conditions; Bioheart that offers preventative care and disease management solutions; and Biokit, a remote patient monitoring kit for cardiac patients that had other chronic conditions such as hypertension or COPD. Biotricity, Inc. is based in Redwood City, California.
Quarterly Financials
| Metric | 2025-03-31 | 2025-06-30 | 2025-09-30 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 3.7M | 3.9M | 3.9M | 4.0M |
| Gross Profit | 3.0M | 3.1M | 3.2M | 3.3M |
| Operating Income | -855K | 282K | 274K | 441K |
| Net Income | -1.9M | -672K | -691K | -717K |
| Diluted EPS | $nan | $-0.03 | $-0.03 | $-0.04 |
Annual Financials
| Metric | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 |
|---|---|---|---|---|
| Revenue | 7.7M | 9.6M | 12.1M | 13.8M |
| Gross Profit | 4.6M | 5.4M | 8.4M | 10.6M |
| Operating Income | -16.7M | -15.4M | -8.8M | -2.4M |
| Net Income | -29.1M | -18.7M | -14.1M | -8.4M |
| Diluted EPS | $-3.99 | $-2.26 | $-1.66 | $-0.56 |